by creavo | Apr 19, 2021 | News, Press Release
The United Kingdom’s National Physical Laboratory (NPL) has worked with Creavo Medical Technologies to better understand the performance and characteristics of our Corsens® imaging technology. As part of NPL’s Measurement for Recovery (M4R) programme NPL have worked...
by creavo | Sep 23, 2020 | News, Press Release
Creavo Medical Technologies Ltd (Creavo), the medical device company developing innovative diagnostics techniques, has announced that it has appointed Martin Frost as Chairman of the Board of Directors. In this role, Martin will drive Creavo’s fundraising plans, and...
by creavo | Nov 22, 2019 | Press Release
22 November 2019: UK medical device company Creavo Medical Technologies (Creavo) has begun a pioneering 510-patient study with University Hospitals Coventry and Warwickshire (UHCW) NHS Trust, to evaluate the role of magnetocardiography (MCG) in the prediction of...
by creavo | Sep 2, 2019 | News, Press Release
August 2019: UK medical device company Creavo Medical Technologies has appointed its Operations Director Andrew Mullen to its Board of Directors, a role which will see him lead on research and development (R&D) and regulatory affairs. Andrew has held the...
by creavo | Jul 19, 2018 | News, Press Release
A new cardiac diagnostic device aimed at helping physicians rule out active ischaemia in patients presenting to the emergency department (ED) with chest pain is being trialled at five of the most respected research facilities in the United States (Mayo Clinic,...
by creavo | May 21, 2018 | News, Press Release
Trial tests the viability of Creavo’s MCG device at five major emergency departments across the UK. Creavo Medical Technologies (Creavo), the UK-based medical device company, has completed patient enrollment in its multi-centre study. Involving 750 patients across...
